Immunohistochemical Basis For Adjuvant Anti-Angiogenic Targeted Therapy For Renal Carcinoid: Initial Case Report

UroToday.com - Although primary renal carcinoids (PRC) are rare tumors, they represent a therapeutic dilemma for urologic oncologists due to tumor heterogeneity and their often unpredictable behavior. While these neuroendocrine tumors have traditionally been classified as low-grade tumors there have been cases associated with progression to metastatic disease and death.

More: continued here

Filed under: Urology on February 20th, 2009